The human papillomavirus vaccine and risk of anaphylaxis

CMAJ. Canadian Medical Association Journal

Volumn 179, Issue 6, 2008, Pages 509-510

  Halsey, Neal A ^a  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EGG PROTEIN; GELATIN; HEPATITIS B VACCINE; IMMUNOGLOBULIN E ANTIBODY; INFLUENZA VACCINE; MEASLES MUMPS RUBELLA VACCINE; POLYSORBATE 80; VIRUS ANTIGEN; WART VIRUS VACCINE; YELLOW FEVER VACCINE;

ANAPHYLAXIS; AUSTRALIA; CAUSAL ATTRIBUTION; DRUG HYPERSENSITIVITY; DRUG SAFETY; EXPERT SYSTEM; HUMAN; IMMEDIATE TYPE HYPERSENSITIVITY; NOTE; PRICK TEST; PUBLIC HEALTH SERVICE; SCHOOL HEALTH SERVICE; SKIN TEST; SYNCOPE; UNITED STATES; VACCINATION;

EID: 51649131421     PISSN: 08203946     EISSN: 14882329     Source Type: Journal    
DOI: 10.1503/cmaj.081133     Document Type: Note

References (12)

1. Brotherton JML, Gold MS, Kemp AS, et al. Anaphylaxis following quadrivalent human papillomavirus vaccination. CMAJ 2008;179:525-33
2. Centers for Disease Control and Prevention. Gardasil Vaccine Reports to VAERS. Atlanta (GA); The Center; 2008. Available: www.cdc.gov/vaccinesafety/ vaers/gardasil.htm (accessed 2008 July 30).
3. Wood RA, Berger M, Dreskin SC, et al. An Algoritm for Management of Patients with Hypersensitivity Reactions Following Vaccines. Pediatrics. In press.
4. Hamilton RG, Adkinson NF Jr. In vitro assays for the diagnosis of IgE-mediated disorders. J Allergy Clin Immunol 2004;114:213-25.
5. Wood RA, Setse R, Halsey N; For the Clinical Immunization Safety Assessment (CISA) Network Hypersensitivity Working Group. Irritant skin test reactions to common vaccines. J Allergy Clin Immunol 2007;120:478-81.
6. Rusznak C, Peebles RS Jr. Anaphylaxis and anaphylactoid reactions. A guide to prevention, recognition, and emergent treatment. Postgrad Med 2002;111:101-4, 107-8, 111-4.
7. Steele RH, Limaye S, Cleland B, et al. Hypersensitivity reactions to the polysorbate contained in recombinant erythropoietin and darbepoietin. Nephrology (Carlton) 2005;10:317-20.
8. Coors EA, Seybold H, Merk HF, et al. Polysorbate 80 in medical products and nonimmunologic anaphylactoid reactions. Ann Allergy Asthma Immunol 2005;95:593-9.
9. Institute for Vaccine Safety. Allergens. Baltimore (MD): Johns Hopkins Bloomberg School of Public Health; 2008. Available: www.vaccinesafety.edu/ components-Allergens.htm (accessed 2008 July 31).
10. Pool V, Braun MM, Kelso JM, et al. VAERS Team. US Vaccine Adverse Event Reporting System. Prevalence of anti-gelatin IgE antibodies in people with anaphylaxis after measles-mumps rubella vaccine in the United States. Pediatrics 2002;110:e71.
11. Centers for Disease Control and Prevention. Syncope After Vaccination - United States, January 2005-July 2007. MMWR Morb Mortal Wkly Rep 2008;57:457-60.
12. Kroger AT, Atkinson WL, Marcuse EK, et al.; Advisory Committee on Immunization Practices Centers for Disease Control and Prevention (CDC). General recommendations on immunization: recommendations of the Advisory Committee on Immunization Practices. MMWR Recomm Rep 2006;55(RR-15):1-48.